| Name | Title | Contact Details |
|---|---|---|
Andy Smith |
National Sales Director | Profile |
Sophia Li |
Director, Global Infusion Marketing | Profile |
Bryan Crawford |
Vice President Finance | Profile |
Mark Novak |
Sr. Director, Global Supply Chain | Profile |
Ron Moulton |
Director, RandD-Electrical Engineering | Profile |
DoctorDirectory - IncreaseRx is a Asheville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has several product candidates in development. LJPC-501 is La Jolla`s proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension. LJPC-401 is La Jolla`s novel formulation of hepcidin for the potential treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. LJPC-30S is our next-generation gentamicin derivative program that is focused on therapeutics for the potential treatment of serious bacterial infections as well as rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy.
Our goal is to provide products and solutions that make a positive, daily difference for people with diabetes. We want to make sure diabetes doesnt get in the way of peoples future, enabling them to live richer lives. At Ascensia Diabetes Care we ...
Brightstone specializes in creating a customized support program for young people needing help through mentoring. Brightstone uses an action oriented approach that creates learning opportunities through real life situations. Our participants move beyon...
Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.